天晟新材(300169.SZ)取得醫療器械經營許可證及第二類醫療器械經營備案憑證
格隆匯5月21日丨天晟新材(300169.SZ)公佈，公司於近日取得了由常州市市場監督管理局頒發的《醫療器械經營許可證》及《第二類醫療器械經營備案憑證》。
《醫療器械經營許可證》經營範圍：2002年分類目錄非IVD批發Ⅲ類醫療器械：6805耳鼻喉科手術器械，6821醫用電子儀器設備，6823醫用超聲儀器及有關設備，6824醫用激光儀器設備，6825醫用高頻儀器設備，6826物理治療及康復設備，6828醫用磁共振設備，6830醫用X射線設備，6845體外循環及血液處理設備，6854手術室、急救室、診療室設備及器具，6856病房護理設備及器具，6858醫用冷療、低温、冷藏設備及器具，6866醫用高分子材料及製品，6870軟件***
2017年分類目錄非IVD批發Ⅲ類醫療器械：01有源手術器械，02無源手術器械，04骨科手術器械，05放射治療器械，06醫用成像器械，07醫用診察和監護器械，08呼吸、麻醉和急救器械，09物理治療器械，10輸血、透析和體外循環器械，14注輸、護理和防護器械，15患者承載器械，16眼科器械，17口腔科器械，18婦產科、輔助生殖和避孕器械，19醫用康復器械，21醫用軟件，22臨牀檢驗器械***
《第二類醫療器械經營備案憑證》經營範圍：2002年分類目錄：非IVD批發：6810矯形外科(骨科)手術器械，6815注射穿刺器械，6820普通診察器械，6822醫用光學器具，儀器及內窺鏡設備，6826物理治療及康復設備，6830醫用X射線設備，6831醫用X射線附屬設備及部件，6840臨牀檢驗分析儀器(體外診斷試劑除外)，6841醫用化驗和基礎設備器具，6854手術室、急救室、診療室設備及器具，6856病房護理設備及器具，6857消毒和滅菌設備及器具，6864醫用衞生材料及敷料，6866醫用高分子材料及製品，6870軟件***
2017年分類目錄：批發：01有源手術器械，04骨科手術器械，05放射治療器械，06醫用成像器械，07醫用診察和監護器械，08呼吸、麻醉和急救器械，09物理治療器械，10輸血、透析和體外循環器械，11醫療器械消毒滅菌器械，14注輸、護理和防護器械，15患者承載器械，16眼科器械，17口腔科器械，18婦產科、輔助生殖和避孕器械，19醫用康復器械，21醫用軟件，22臨牀檢驗器械***
公司此次取得《醫療器械經營許可證》及《第二類醫療器械經營備案憑證》後即可開展相關業務活動，有助於公司在相關業務領域的進一步發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
